Abstract
For decades, neurologic and pulmonary disorders have been associated to diabetes mellitus (DM) and more recently to obesity. Many studies have attempted to establish the association between sleep apnea and adult-onset DM. Growing evidence exists demonstrating the association between insulin-resistance and obstructive sleep apnea (OSA), as well as sleep-disordered breathing (SDB) in non-obese diabetic patients with autonomic neuropathy. In patients with DM, two types of sleep disorders can be found; upper airway resistance syndrome and sleep apnea. The later apnea can be central, obstructive or mixed. In either case, a decrease in the oxygen saturation will ensue, and sleep arousal will occur. The diagnosis of sleep apnea in patients with DM is mainly done by obtaining a good history and physical examination. The main symptoms in the patient with sleep apnea include excessive daytime sleepiness (frequently seen in situations which are not mentally demanding). Effective continued positive airway pressure (CPAP) treatment show clinical improvement in symptoms as well as in insulin sensitivity. The relation between SDB and DM can have significant impact on the overall health of the patient.
Keywords: Sleep apnea, sleep-related disorders, insulin resistance, diabetes mellitus, obesity
Current Respiratory Medicine Reviews
Title: Sleep-Related Disorders, Diabetes and Obesity: Understanding the Facts
Volume: 2 Issue: 3
Author(s): Javier Nieto, Salim Surani, Ana L. Huerta-Alardin and Joseph Varon
Affiliation:
Keywords: Sleep apnea, sleep-related disorders, insulin resistance, diabetes mellitus, obesity
Abstract: For decades, neurologic and pulmonary disorders have been associated to diabetes mellitus (DM) and more recently to obesity. Many studies have attempted to establish the association between sleep apnea and adult-onset DM. Growing evidence exists demonstrating the association between insulin-resistance and obstructive sleep apnea (OSA), as well as sleep-disordered breathing (SDB) in non-obese diabetic patients with autonomic neuropathy. In patients with DM, two types of sleep disorders can be found; upper airway resistance syndrome and sleep apnea. The later apnea can be central, obstructive or mixed. In either case, a decrease in the oxygen saturation will ensue, and sleep arousal will occur. The diagnosis of sleep apnea in patients with DM is mainly done by obtaining a good history and physical examination. The main symptoms in the patient with sleep apnea include excessive daytime sleepiness (frequently seen in situations which are not mentally demanding). Effective continued positive airway pressure (CPAP) treatment show clinical improvement in symptoms as well as in insulin sensitivity. The relation between SDB and DM can have significant impact on the overall health of the patient.
Export Options
About this article
Cite this article as:
Nieto Javier, Surani Salim, Huerta-Alardin L. Ana and Varon Joseph, Sleep-Related Disorders, Diabetes and Obesity: Understanding the Facts, Current Respiratory Medicine Reviews 2006; 2 (3) . https://dx.doi.org/10.2174/157339806778019006
DOI https://dx.doi.org/10.2174/157339806778019006 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
IL-1 as a target in inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma
Current Cancer Drug Targets Simvastatin: Review of Updates on Recent Trends in Pharmacokinetics, Pharmacodynamics, Drug–drug Interaction, Impurities and Analytical Methods
Current Pharmaceutical Analysis The Role of SHP-2 in Cell Signalling and Human Disease
Current Enzyme Inhibition Effect of Danggui-Shaoyao-San-Containing Serum on the Renal Tubular Epithelial-Mesenchymal Transition of Diabetic Nephropathy
Current Pharmaceutical Biotechnology Mild Carbohydrate Intolerance in Pregnancy
Current Diabetes Reviews Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients
Current Vascular Pharmacology Skeletal Muscle Insulin Resistance as a Precursor to Diabetes: Beyond Glucoregulation
Current Diabetes Reviews Can Life Before Birth Affect Health Ever After?
Current Women`s Health Reviews Oxidative Stress, HDL and Atherosclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Current Options in the Treatment of Mitochondrial Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Use of microRNAs as Anti-Atherosclerosis
Mini-Reviews in Medicinal Chemistry Contribution of ALDH2 Polymorphism to Alcoholism-Associated Hypertension
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Exocrine Pancreas Involvement in Celiac Disease: A Review
Recent Patents on Inflammation & Allergy Drug Discovery Ursolic Acid and Oleanolic Acid: Pentacyclic Terpenoids with Promising Anti-Inflammatory Activities
Recent Patents on Inflammation & Allergy Drug Discovery Transgenic Mouse Models of Parkinsons Disease and Huntingtons Disease
CNS & Neurological Disorders - Drug Targets Have We Learnt all from IMPROVE-IT? Part II. Subanalyses of the Effects of Ezetimibe Added to Statin Therapy on Selected Clinical and Laboratory Outcomes, Cost-Effectiveness, Guidelines, and Clinical Implications
Current Vascular Pharmacology Anti-Tumor Necrosis Factor Blocking Agents in the Treatment of Systemic Vasculitis
Current Immunology Reviews (Discontinued) GABAergic Modulation in Diabetic Encephalopathy-Related Depression
Current Pharmaceutical Design Niacin Status, NAD Distribution and ADP-Ribose Metabolism
Current Pharmaceutical Design